Cargando…
Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis
BACKGROUND: Circulating microRNA-21 (miR-21) is known to be aberrantly expressed in hepatocellular carcinoma (HCC) patients, and this implies that microRNA-21 is a promising and novel indicator of HCC. However, a systematic evaluation of the performance of microRNA-21 as a diagnostic marker for HCC...
Autores principales: | Liao, Qibin, Han, Peiyu, Huang, Yue, Wu, Zhitong, Chen, Qing, Li, Shanshan, Ye, Jufeng, Wu, Xianbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483261/ https://www.ncbi.nlm.nih.gov/pubmed/26114756 http://dx.doi.org/10.1371/journal.pone.0130677 |
Ejemplares similares
-
Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis
por: Zhao, Xiao-Fei, et al.
Publicado: (2020) -
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
por: Pelizzaro, Filippo, et al.
Publicado: (2021) -
Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children
por: Li, Jun, et al.
Publicado: (2016) -
Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension
por: DÜZGÜN, Zekeriya, et al.
Publicado: (2022) -
Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma
por: Wang, Ji Yu, et al.
Publicado: (2017)